Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Healthlead PCL's Enterprise Value is ฿1,213 Mil.
Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ฿113 Mil. Therefore, Healthlead PCL's EV-to-EBIT ratio for today is 10.76.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Healthlead PCL's Enterprise Value is ฿1,213 Mil.
Healthlead PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ฿208 Mil. Therefore, Healthlead PCL's EV-to-EBITDA ratio for today is 5.83.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Healthlead PCL's Enterprise Value is ฿1,213 Mil.
Healthlead PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2,244 Mil. Therefore, Healthlead PCL's EV-to-Revenue ratio for today is 0.54.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Healthlead PCL's Enterprise Value is ฿1,213 Mil.
Healthlead PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ฿152 Mil. Therefore, Healthlead PCL's EV-to-FCF ratio for today is 7.99.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Healthlead PCL (BKK:HL) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Healthlead PCL's current Enterprise Value is ฿1,213 Mil.
Healthlead PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿113 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Healthlead PCL's current Enterprise Value is ฿1,213 Mil.
Healthlead PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿208 Mil.
Healthlead PCL's current Enterprise Value is ฿1,213 Mil.
Healthlead PCL's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2,244 Mil.
Healthlead PCL's current Enterprise Value is ฿1,213 Mil.
Healthlead PCL's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿181 Mil.
Healthlead PCL's current Enterprise Value is ฿1,213 Mil.
Healthlead PCL's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿152 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL Enterprise Value Related Terms
Healthlead PCL Enterprise Value Historical Data
* Premium members only.
The historical data trend for Healthlead PCL's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL Enterprise Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Healthlead PCL's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthlead PCL Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Healthlead PCL's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Healthlead PCL's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthlead PCL (BKK:HL) has a Enterprise Value of ฿1,213 Mil as of Jul. 06, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Enterprise Value too high?
Healthlead PCL's current Enterprise Value is ฿1,213 Mil. Overall, Healthlead PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Enterprise Value compare to competitors?
Healthlead PCL's Enterprise Value of ฿1,213 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Enterprise Value is ฿1,213 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.85, compared to a current price of ฿5.60 — trading 48.4% below its estimated fair value. The current Enterprise Value is ฿1,213 Mil. Healthlead PCL's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Enterprise Value is ฿1,213 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthlead PCL (BKK:HL) Overvalued in 2026?
Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued.
The current stock price of ฿5.60 is trading 48.4% below its estimated GF Value™ of ฿10.85.
GuruFocus considers Healthlead PCL to be Significantly Undervalued.
Key valuation signals for BKK:HL:
Enterprise Value: ฿1,213 Mil
GF Value™: ฿10.85 vs. price of ฿5.60 (48.4% below fair value)
No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
72GF Score
Get the complete analysis for BKK:HL
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HL has been successfully added to your 
